Susquehanna International Group
GBT

Susquehanna International Group’s Global Blood Therapeutics, Inc. GBT Stock Holding History

Susquehanna International Group’s Portfolio GBT Stock Details GBT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-47,540
Closed -$3.24M – 14656
2022
Q3 		$3.24M Buy
47,540
+32,468
+215% +$1.79M ﹤0.01% 3929
2022
Q2 		$482K Sell
15,072
-39,883
-73% -$1.17M ﹤0.01% 8354
2022
Q1 		$1.9M Sell
54,955
-73,037
-57% -$2.18M ﹤0.01% 5589
2021
Q4 		$3.75M Sell
127,992
-47,693
-27% -$1.48M ﹤0.01% 4254
2021
Q3 		$4.48M Buy
175,685
+9,281
+6% +$273K ﹤0.01% 4164
2021
Q2 		$5.83M Buy
166,404
+42,376
+34% +$1.65M ﹤0.01% 3750
2021
Q1 		$5.05M Buy
124,028
+31,059
+33% +$1.43M ﹤0.01% 3896
2020
Q4 		$4.03M Sell
92,969
-103,851
-53% -$5.12M ﹤0.01% 3797
2020
Q3 		$10.9M Buy
196,820
+87,939
+81% +$5.59M ﹤0.01% 2077
2020
Q2 		$6.87M Sell
108,881
-50,767
-32% -$3.48M ﹤0.01% 2592
2020
Q1 		$8.16M Buy
159,648
+127,411
+395% +$8.53M ﹤0.01% 1978
2019
Q4 		$2.56M Sell
32,237
-189,207
-85% -$11.2M ﹤0.01% 3929
2019
Q3 		$10.7M Sell
221,444
-699
-0.3% -$36.4K ﹤0.01% 1897
2019
Q2 		$11.7M Buy
+222,143
New +$12.8M ﹤0.01% 1741
2019
Q1 		– Sell
-208,468
Closed -$10.2M – 10166
2018
Q4 		$8.56M Buy
208,468
+174,544
+515% +$6.54M ﹤0.01% 1756
2018
Q3 		$1.29M Sell
33,924
-203,885
-86% -$9.03M ﹤0.01% 4758
2018
Q2 		$10.7M Buy
+237,809
New +$10.8M ﹤0.01% 1861
2018
Q1 		– Sell
-116,424
Closed -$6.49M – 10467
2017
Q4 		$4.58M Buy
+116,424
New +$4.35M ﹤0.01% 2633
2017
Q2 		– Sell
-95,230
Closed -$2.83M – 10043
2017
Q1 		$3.51M Buy
+95,230
New +$2.4M ﹤0.01% 2794
2016
Q3 		– Sell
-48,495
Closed -$924K – 9251
2016
Q2 		$805K Buy
+48,495
New +$978K ﹤0.01% 5285
2015
Q4 		– Sell
-10,912
Closed -$460K – 10162
2015
Q3 		$460K Buy
+10,912
New +$515K ﹤0.01% 7285

Other funds holding GBT

BTI
Blue Trust Inc Alpharetta, Georgia $9.54B AUM 19.86% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Susquehanna International Group's GBT Position: Q4 2022 in Review

Susquehanna International Group sold out of Global Blood Therapeutics, Inc. (GBT) in Q4 2022, closing a stake of 47,540 shares — an estimated $3.24M sold.

Susquehanna International Group first reported a position in GBT in Q3 2015 and held it in 21 quarters. The position peaked at $11.7M in Q2 2019. 2 funds tracked by Wall St. Rank hold GBT as of Q4 2022.

  • Susquehanna International Group reported no remaining Global Blood Therapeutics, Inc. position as of Q4 2022 after selling out during the quarter.
  • Susquehanna International Group sold 47,540 Global Blood Therapeutics, Inc. shares in Q4 2022, an estimated $3.24M.
  • Susquehanna International Group first reported a position in Global Blood Therapeutics, Inc. in Q3 2015 and held it in 21 quarters.
  • Susquehanna International Group's Global Blood Therapeutics, Inc. position peaked at $11.7M in Q2 2019.
  • 2 funds tracked by Wall St. Rank held Global Blood Therapeutics, Inc. as of Q4 2022.

Based on Susquehanna International Group's 13F filing for Q4 2022, filed 14 Feb 2023.